Michael L. Miller

Disease activity score for children with juvenile dermatomyositis: Reliability and validity evidence

Rita Bode, Marisa S. Klein‐Gitelman, Michael L. Miller et al. · Arthritis Care & Research · 2003 · 262 citations

Medicine, Dermatology, Pediatrics +13

<i>HLA-DRB1*11</i> and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

Michael J. Ombrello, Elaine F. Remmers, Ioanna Tachmazidou et al. · Proceedings of the National Academy of Sciences · 2015 · 185 citations · Full text

Life Sciences, Genetics, Immunology +17

Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis

Norman T. Ilowite, Kristi Prather, Yuliya Lokhnygina et al. · Arthritis & Rheumatology · 2014 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Intravenous nitroglycerin-induced heparin resistance: A qualitative antithrombin III abnormality

Richard C. Becker, Jeanne M. Corrao, Edwin G. Bovill et al. · American Heart Journal · 1990 · 83 citations

Medicine, Internal Medicine, Pharmacology +12

Typical and Atypical Chronic Lymphocytic Leukemia Differ Clinically and Immunophenotypically

John L. Frater, Karen F. McCarron, Jeffrey Hammel et al. · American Journal of Clinical Pathology · 2001 · 77 citations · Full text

Medicine, Hematology, Pathology +13